Category Pharmaceutical Industry

North Dakota to Receive Nearly $3 Million in Whistleblower Lawsuit [Legal Monitor Worldwide]

Dec31

The state of North Dakota will be receiving nearly $3 million for its state Medicaid program as part of a whistleblower settlement between the federal government and a major pharmaceutical company.A Tuesday release from the North Dakota Department of Human Services announced that the state Medicaid program will receive about $2.99 million. The money comes […]

IGI Laboratories, Inc. Completes Its Sixth ANDA Filing For 2013 Under Joint Drug Development And Commercialization Agreement

Dec31

BUENA, N.J., Dec. 31, 2013 /PRNewswire/ IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based generic topical pharmaceutical company, today announced it executed a license, development, supply and marketing agreement with a large multi-national pharmaceutical company. In accordance with the confidentiality agreement in place, the name of the company remains undisclosed. The agreement designates […]

Adamis Pharmaceuticals Corp. Files SEC Form 8-K, Current Report (Dec. 18, 2013)

Dec30

By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Adamis Pharmaceuticals Corp. (Form 8-K) was posted on December 18, 2013.The SIC code for this company is 2834, Pharmaceutical Preparations.There were 2 documents filed with […]

Boehringer Ingelheim Pharmaceuticals Inc. Earns CEO Cancer Gold Standard Accreditation

Dec30

By a News Reporter-Staff News Editor at Pharma Business Week Boehringer Ingelheim Pharmaceuticals, Inc., the largest U.S. subsidiary of Boehringer Ingelheim Corporation, based in Ridgefield, CT, is leading by example when it comes to promoting workplace wellness and encouraging healthier behavior. The CEO Roundtable on Cancer has awarded Boehringer Ingelheim with CEO Cancer Gold StandardTM […]

Transcept Pharmaceuticals Inc. Files SEC Form SC 13G, Statement of Acquisition of Beneficial Ownership By Individuals (Dec. 18, 2013)

Dec30

By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Transcept Pharmaceuticals Inc. (Form SC 13G) was posted on December 18, 2013.The SIC code for this company is 2834, Pharmaceutical Preparations.There was one document filed […]

In Health Science IT, Scan is the New Four-letter Word

Dec30

Rancho Cordova, California (PRWEB) December 30, 2013 Health science companies are becoming increasingly concerned with the exorbitant labor costs and quality issues created by document scanning and related manual paper-based processes. As companies learn more about the cost of digitizing paper documents, Scan is becoming the industry’s new four-letter word. To help BioPharma companies quantify […]

Provectus Pharmaceuticals Inc. Files SEC Form 8-K, Current Report (Dec. 17, 2013)

Dec30

By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Provectus Pharmaceuticals Inc. (Form 8-K) was posted on December 17, 2013.The SIC code for this company is 2834, Pharmaceutical Preparations.There were 2 documents filed with […]

Patent Issued for Method of Formation of a Medical Implant

Dec30

By a News Reporter-Staff News Editor at Pharma Business Week From Alexandria, Virginia, NewsRx journalists report that a patent by the inventor Schuessler, David J. (Ventura, CA), filed on November 3, 2011, was published online on December 17, 2013 (see also Pharmaceutical Companies).The patent’s assignee for patent number 8609004 is Allergan, Inc. (Irvine, CA).News editors […]

New Clinical Trials and Studies Data Have Been Reported by Researchers at Royal Children’s Hospital

Dec30

By a News Reporter-Staff News Editor at Clinical Trials Week Investigators publish new report on Clinical Research. According to news reporting originating in Melbourne, Australia, by NewsRx journalists, research stated, “The myocardial protective effect of remote ischemic preconditioning has been demonstrated in heterogeneous groups of patients undergoing cardiac surgery. No studies have examined this technique […]

Cubist Pharmaceuticals Inc. Files SEC Form 8-K, Current Report (Dec. 16, 2013)

Dec30

By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Cubist Pharmaceuticals Inc. (Form 8-K) was posted on December 16, 2013.The SIC code for this company is 2834, Pharmaceutical Preparations.There were 3 documents filed with […]